Viro Perspectives
Learn more on the topic of Varicella Zoster Virus (VZV) via our ongoing series of clinical posts by David Kilpatrick, PhD and Abbas Vafai, PhD.
INTRODUCTION: Patients have a higher risk of HZ with diseases such as rheumatoid arthritis (RA), psoriasis (PsO), and inflammatory bowel-related diseases (IBD) such as ulcerative colitis (UC) and Crohn’s disease (CD). Using immunosuppressive therapy, which treats these diseases, increases the risk of HZ. DISCUSSION: The most common risk factor for HZ is increasing age, presumably […]
INTRODUCTION: Oral fluids have been used to detect Herpes virus antibodies, including secretory IgA, IgM, and IgG. Herpes virus particles have also been identified in saliva. Several Herpes viruses, such as Epstein–Barr virus (EBV), varicella-zoster virus (VZV), and herpes-simplex-1 (HSV-1), have even been detected in the saliva of Astronauts from shuttle-flights and ISS missions . […]
Abbas Vafai, Ph.D. inventor of shingles vaccine, SHINGRIX, develops ZosterGent® VZV Identification Reagent, a more sensitive test in detecting the shingles virus. SNELLVILLE, Ga., June 9, 2020 (Newswire.com) – Viro Research, developer of high quality biologics and reagents, announced today the launch of ZosterGent® for lesion testing of at-risk patients suspected of having chickenpox or […]